JK Agri Genetics Schedules Board Meeting for May 8, 2026 to Approve FY26 Results and Consider Dividend

JK Agri Genetics has scheduled a Board of Directors meeting for May 8, 2026, to review and approve crucial financial matters for the concluded financial year. The company issued the formal intimation on May 1, 2026, in compliance with regulatory requirements under SEBI listing obligations.

Board Meeting Agenda

The board meeting will address two primary matters of significant importance to shareholders and stakeholders:

Agenda Item Details Financial Results Approval Standalone and Consolidated Audited Financial Results for Q4 and FY ended March 31, 2026 Dividend Consideration Recommendation of dividend on equity shares of Rs. 10 each for FY ended March 31, 2026

Trading Window Restrictions

In accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015, and the company's Code of Conduct for designated persons, JK Agri Genetics has implemented trading window restrictions. The trading window closure and reopening schedule follows regulatory compliance requirements:

Parameter Date Trading Window Closure April 1, 2026 Board Meeting Date May 8, 2026 Trading Window Reopening May 11, 2026

The trading window restrictions ensure compliance with insider trading regulations during the period leading up to and following the announcement of financial results. This measure protects market integrity and prevents any potential misuse of unpublished price-sensitive information.

Regulatory Compliance

The board meeting intimation has been filed under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Anoop Singh Gusain signed the formal communication, ensuring adherence to corporate governance standards and regulatory timelines.

The meeting outcomes, particularly the financial results and any dividend announcement, will be crucial for investors and market participants to assess the company's performance for the financial year ended March 31, 2026.

JK Agri Genetics Limited has disclosed receiving an income tax order from the Commissioner of Income Tax – Appeals regarding the disallowance of research and development expenses for Financial Year 2017-18. The communication was received on 17th April 2026 through the National Faceless Appeal Centre (NFAC), Delhi.

Background of the Tax Matter

The current development stems from an ongoing tax dispute that began with the company's income tax return filed for Financial Year 2017-18. In April 2021, the IT Department passed an assessment order disallowing expenses of ₹9.89 crore, specifically the weighted deduction of 150% under section 35(2AB) of the IT Act on R&D expenses of ₹6.59 crore. The initial tax impact was calculated at ₹3.42 crore, with the disallowance based on non-receipt of Form 3CL from the Department of Scientific and Industrial Research (DSIR).

Current Order Details

Parameter: Details Order Type: Order U/S 250 of Income Tax Act, 1961 Authority: Commissioner of Income Tax – Appeals Date Received: 17th April 2026 Disallowed Amount: ₹1.50 crore (labour expenses) Tax Demand: ₹0.52 crore

In April 2023, DSIR had disallowed only ₹1.50 crore towards labour expenses that were outsourced in nature and subsequently filed Form 3CL with the IT Department. Based on this development and the company's appeal, the Commissioner of Income Tax (Appeals) has now passed an order confirming the disallowance of ₹1.50 crore of labour expenses as per the Form 3CL issued by DSIR.

Financial Impact

The financial implications of this order are limited due to the company's tax position:

Demand Amount: ₹0.52 crore (including applicable interest)

Cash Impact: No cash outflow expected

Adjustment Mechanism: The demand will be adjusted against available MAT credit

The company has confirmed that the demand amount will be set off against its existing Minimum Alternate Tax (MAT) credit balance, eliminating the need for any cash payment.

Company's Response Strategy

JK Agri Genetics Limited is actively considering its legal options in response to this order. The company has indicated that it is contemplating filing an appeal against the Commissioner (Appeals) order before the Income Tax Appellate Tribunal (ITAT). The prescribed timeline for filing such an appeal is within sixty days of receipt of the order.

Compliance and Disclosure

The company has made this disclosure in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure confirms that no penalties, restrictions, or sanctions have been imposed pursuant to this communication, and no aberrations or non-compliances have been identified by the tax authority in the current order.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.